NCT02457403View on ClinicalTrials.gov

Comparison of Blood Product Use and Bleeding Events During and After Endoscopic or Neurosurgical Procedures in Patients With Cirrhosis and Coagulopathy

NACompletedINTERVENTIONAL
Enrollment

68

Participants

Timeline

Start Date

May 31, 2015

Primary Completion Date

November 30, 2018

Study Completion Date

November 30, 2018

Conditions
CirrhosisCoagulopathy
Interventions
DEVICE

ROTEM

Assess coagulopathy with ROTEM device compared to conventional laboratory tests. ROTEM will be used on all patients, however, determination of blood products used will be based on patient's randomization group.

OTHER

Conventional Therapy

Assess coagulopathy with conventional laboratory tests (PT/INR, Hemoglobin, Platelet count). Conventional laboratory tests will be obtained on all subjects, however, determination of blood products used will be based on patient's randomization group.

All Listed Sponsors
lead

Ohio State University

OTHER

NCT02457403 - Comparison of Blood Product Use and Bleeding Events During and After Endoscopic or Neurosurgical Procedures in Patients With Cirrhosis and Coagulopathy | Biotech Hunter | Biotech Hunter